The latest news from academia, regulators
research labs and other things of interest
Posted: October 20, 2008
Nanoliter Spectrophotometer Manufacturer Trinean Raises 3.5M Euro Funding
(Nanowerk News) Trinean NV, an innovative player
in the sector of molecular instrumentation, today announced the closure of
a 3.5 million Euro round of financing. The round was co-lead by new
investor Vesalius Biocapital and existing investor Capital-E. Trinean
(www.trinean.com) is a spin-off of the University of Ghent (Intec) and the
Belgium nanoelectronics research center IMEC. The company develops and
markets the first nanoliter spectrophotometer with corresponding micro
fluidic consumables allowing full spectrum UV/VIS spectroscopic
measurements in droplets of liquids between 0,5 and 2,5 µL in a microplate
format in a very fast and automated way.
The initial target application is the determination of DNA/RNA
concentrations in small sample volumes. This is of great importance to the
biotech industry where today valuable DNA/RNA material has to be sacrificed
in order to measure these concentrations, and where test procedures are
Next to DNA/RNA quantification, other applications will also be targeted
such as ADME testing, protein concentration measurements, enzymology,
nephelometry and clinical diagnostics.
The investment round will allow Trinean to start production, bring its
products to the market and develop new applications.
The company is run by a senior management team consisting of Jan Boon
(COO), (ex-Elscolab, Thermo Life Sciences, Flow Laboratories , Pharmacia
DiagnosticsΣ.) and Prof. Marc Zabeau (CEO) (ex- Plant Genetic Systems,
Helix, KeyeGene, Genscope, Methexis...).
Trinean is a developer and producer of nanoliter spectrophotometers and
consumables for the scientific market. The use of a unique polychromatic
spectroscopy system combined with microfluidic chips in microplate format,
provides the world-wide scientists a gain of time, accuracy and costly
samples and reagents, which is of high importance to the biotech
applications. More information can be obtained at www.trinean.com.
About Vesalius Biocapital
Capital-E is an early stage venture fund focused exclusively on micro- and
nano-electronics related ventures in Europe. We help initiate and grow
businesses with venture capital, sound advice and access to a broad
industry network and research ecosystem. Through its entrenched
relationship with IMEC, a world-leading independent research centre in
nano-electronics, the fund and its ventures can directly rely on the
support of over 1600 specialised scientists and engineers, as well as
leverage on IMEC's 1000+ worldwide industrial partners to speed-up the
process of market entry. The fund is managed by an independent team with a
balanced mix of entrepreneurial, industrial and VC experience. More
information can be obtained at www.capital-e.com.